A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients

BACKGROUND: The AURA3 clinical trial has shown that advanced non-small cell lung cancer (NSCLC) patients with EGFR T790M mutations in circulating tumor DNA (ctDNA) could benefit from osimertinib. PURPOSE: The aim of this study was to assess the usefulness of QuantStudio™ 3D Digital PCR System platfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qin, Gai, Fei, Sang, Yaxiong, Zhang, Jie, Wang, Ping, Wang, Yue, Liu, Bing, Lin, Dongmei, Yu, Yang, Fang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783148/
https://www.ncbi.nlm.nih.gov/pubmed/29403309
http://dx.doi.org/10.2147/CMAR.S148134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783148/
https://www.ncbi.nlm.nih.gov/pubmed/29403309
http://dx.doi.org/10.2147/CMAR.S148134

Ejemplares similares